SELP Monoclonal Antibody,FITC Conjugated

Shipped with Ice Packs
In Stock

Product Specs

Form
Phosphate-buffered solution, pH 7.4, containing 0.09% sodium azide and 0.2% (w/v) bovine serum albumin (BSA)
Lead Time
We typically dispatch orders for SELP Monoclonal Antibody, FITC Conjugated within 1-3 business days of receipt. Delivery times may vary depending on the chosen shipping method and destination. For specific delivery estimates, please contact your local distributor.

Q&A

What is the optimal storage condition for SELP monoclonal antibody, FITC conjugated reagents to maintain fluorescence integrity?

SELP monoclonal antibody conjugated with FITC should be stored in PBS buffer at pH 7.2 containing 1% BSA and 0.05% sodium azide at cool temperature (2-8°C) for short-term storage or frozen (-20°C) for long-term storage. Avoid repeated freeze-thaw cycles as this can significantly reduce antibody activity and fluorescence intensity. For FITC-conjugated antibodies specifically, storage in dark conditions is critical as exposure to light can cause photobleaching of the fluorophore . Research indicates that properly stored FITC-conjugated antibodies maintain approximately 90% of their fluorescence intensity for up to 12 months when stored at -20°C to -70°C under sterile conditions after reconstitution .

How should I determine the optimal concentration of FITC-conjugated SELP antibody for flow cytometry experiments?

For optimal performance in flow cytometry applications, FITC-conjugated SELP antibodies should be carefully titrated. Begin with ≤0.5 μg of antibody per test (defined as the amount needed to stain a cell sample in a final volume of 100 μL). Testing indicates that if used at higher concentrations, binding of some monoclonal antibodies can quench FITC fluorescence, reducing signal intensity .

The optimal cell number should be determined empirically but typically ranges from 10^5 to 10^8 cells per test. For accurate titration:

  • Prepare a serial dilution of the antibody (e.g., 0.05-1.0 μg)

  • Maintain consistent cell numbers across all samples

  • Plot the signal-to-noise ratio against antibody concentration

  • Select the concentration that provides maximum specific signal with minimal background

This approach ensures both specificity and sensitivity while minimizing reagent waste .

What controls should be included when using FITC-conjugated SELP monoclonal antibodies in flow cytometry experiments?

To ensure reliable and interpretable results when using FITC-conjugated SELP monoclonal antibodies, include the following controls:

  • Autofluorescence control: Unstained cells to establish baseline fluorescence

  • Isotype control: FITC-conjugated mouse IgG1 (matching the SELP antibody isotype) to identify non-specific binding

  • Blocking controls: Two types recommended:

    • Pre-incubation of the FITC-conjugated antibody with recombinant SELP protein

    • Pre-incubation of fixed/permeabilized cells with excess unlabeled SELP antibody prior to staining with FITC-conjugated antibody

  • Single-color controls: For compensation when performing multicolor flow cytometry

The quadrant markers for bivariate dot plots should be set based on the autofluorescence control and verified with blocking controls . This comprehensive control strategy enables accurate discrimination between specific and non-specific binding, critical for reliable data interpretation.

How do I determine if my FITC-conjugated SELP antibody is detecting cell surface expression versus intracellular expression?

To differentiate between cell surface and intracellular SELP detection:

  • For surface expression: Harvest cells using a non-enzymatic cell dissociation solution (to preserve surface epitopes) and perform staining on intact cells without permeabilization.

  • For intracellular expression: Harvest cells using standard methods (e.g., trypsin-EDTA), fix them, and then permeabilize before antibody staining.

  • Comparative analysis: Measure median fluorescence intensity in both preparations to quantify relative distribution.

In experimental studies analyzing membrane proteins, researchers have demonstrated that comparing surface versus intracellular staining can reveal important insights about protein trafficking. For example, when geldanamycin (3 μM) was used to interfere with protein secretion, the presentation of some membrane antigens increased by 42-101% at the cell surface while decreasing by approximately 42% intracellularly . This approach allows for distinguishing between trafficking defects and expression level changes.

What methodological approaches can resolve potential signal quenching issues when using FITC-conjugated SELP monoclonal antibodies?

Signal quenching can significantly impact the sensitivity of FITC-conjugated antibody detection. Research has identified several methodological solutions:

What are the critical parameters for conjugating FITC to purified SELP monoclonal antibodies in-house, and how can conjugation efficiency be optimized?

For researchers synthesizing their own FITC-conjugated SELP antibodies, the following critical parameters must be controlled:

  • Antibody purification: Purify monoclonal antibodies using Protein G chromatography to remove serum proteins that could compete for FITC binding .

  • Dialysis conditions:

    • Dialyze purified antibody against FITC labeling buffer (500 mL) at 4°C

    • Perform 2-3 buffer changes over 48 hours (≥4 hours between changes)

    • Final pH should be 9.2, which is optimal for the FITC conjugation reaction

  • FITC:antibody ratio optimization:

    • Add 20 μL of 5 mg/mL FITC in anhydrous DMSO per mg of antibody

    • Incubate for 2 hours at room temperature

    • FITC and DMSO must be anhydrous; prepare immediately before use

  • Removal of unconjugated FITC:

    • Dialyze against 500 mL final dialysis buffer at 4°C

    • Perform 2-3 buffer changes over 48 hours

  • Conjugation efficiency assessment:

    • Calculate the fluorochrome/protein (F/P) ratio by spectrophotometric analysis

    • Optimal F/P ratio for FITC-antibody conjugates is 3-7 fluorophore molecules per antibody

    • Higher ratios may cause self-quenching; lower ratios reduce sensitivity

This methodological approach ensures consistent, high-quality FITC-conjugated antibodies for research applications.

How can I validate the specificity of SELP detection with FITC-conjugated monoclonal antibodies at the cell surface?

Validating the specificity of SELP detection requires a multi-faceted approach:

  • Biotinylation of cell surface proteins:

    • Grow cells to confluence

    • Biotinylate membrane proteins and peptides

    • Lyse cells and purify biotinylated proteins using streptavidin-agarose beads

    • Analyze purified material by SDS-PAGE and Western blot with anti-SELP antibodies

  • Cross-validation with multiple antibodies:

    • Test multiple antibody clones recognizing different SELP epitopes

    • Compare staining patterns between polyclonal and monoclonal antibodies

    • Verify that different antibodies recognize the same molecular weight protein

  • Competitive binding assays:

    • Pre-incubate cells with excess unlabeled anti-SELP antibody

    • Follow with FITC-conjugated anti-SELP antibody

    • Confirm reduced binding, demonstrating epitope-specific competition

  • Recombinant protein blocking:

    • Pre-incubate FITC-conjugated antibody with recombinant SELP protein

    • Apply to cells and confirm reduced binding

    • This demonstrates antigen-specific binding

  • FACS comparative analysis:

    • Compare median fluorescence intensity between specific and control samples

    • Specific antibody should provide significantly higher signal (typically 10-100 times) compared to controls

This comprehensive validation strategy ensures that observed signals truly represent SELP expression rather than non-specific binding.

What methodological approaches can distinguish between different glycoforms of SELP when using FITC-conjugated monoclonal antibodies?

SELP (selectin P) exists in multiple glycoforms that may have distinct functional properties. To distinguish between these forms:

  • Epitope-specific monoclonal antibodies:

    • Select antibody clones that specifically recognize glycosylated epitopes

    • For example, some monoclonal antibodies specifically recognize fucosylated O-glycan structures linked to selectins

  • Enzymatic deglycosylation controls:

    • Treat one sample set with specific glycosidases (e.g., PNGase F for N-glycans, O-glycosidase for O-glycans)

    • Compare FITC-staining patterns before and after deglycosylation

    • Loss of binding after deglycosylation confirms glycan-dependent epitopes

  • Lectin co-staining:

    • Perform dual staining with FITC-conjugated anti-SELP and a different fluorophore-conjugated lectin

    • Select lectins with known glycan specificities (e.g., UEA-I for α-linked fucose)

    • Co-localization indicates the presence of specific glycan structures

  • Glycosylation inhibitor studies:

    • Treat cells with glycosylation inhibitors (e.g., tunicamycin for N-glycans)

    • Monitor changes in FITC-antibody binding

    • This approach reveals the contribution of specific glycan types to antibody recognition

  • Mass spectrometry validation:

    • Immunoprecipitate SELP using the FITC-conjugated antibody

    • Analyze glycan structures by mass spectrometry

    • Correlate antibody binding with specific glycan compositions

These methods enable researchers to discriminate between functional SELP glycoforms, providing insights into their biological roles.

How can FITC-conjugated SELP monoclonal antibodies be effectively used in multicolor flow cytometry panels to analyze selectin-dependent cellular interactions?

Designing effective multicolor panels including FITC-conjugated SELP antibodies requires strategic planning:

  • Spectral compatibility considerations:

    • FITC excitation: 488 nm; emission: 520 nm

    • Avoid fluorophores with significant spectral overlap (PE-Cy5, PerCP)

    • Optimal panel fluorophores include PE (574 nm), APC (660 nm), and PE-Cy7 (785 nm)

  • Panel design strategy:

    • Assign FITC to SELP if expression is high or medium

    • For low SELP expression, use brighter fluorophores (PE, APC) and assign FITC to abundantly expressed markers

    • Include lineage markers conjugated to spectrally distinct fluorophores

  • Compensation controls:

    • Prepare single-stained controls for each fluorophore using the same cells

    • Include FMO (Fluorescence Minus One) controls to set accurate gates

    • Anti-FITC beads can serve as stable compensation controls

  • Sample preparation optimization:

    • For activated platelets or endothelial cells, minimize processing time to prevent selectin shedding

    • Use calcium-containing buffers when analyzing selectin-dependent interactions

    • Consider fixation impact on SELP epitopes (some fixatives may alter binding)

  • Data analysis approach:

    • Implement hierarchical gating strategies (e.g., viability → lineage → activation markers → SELP)

    • For co-expression studies, use bivariate plots with quadrant statistics

    • Consider dimension reduction techniques (tSNE, UMAP) for complex datasets

This comprehensive approach enables detailed analysis of SELP in the context of cellular interactions and activation states.

What methodological approaches can resolve contradictory results between FITC-conjugated SELP antibody staining and functional SELP-dependent adhesion assays?

When FITC-conjugated SELP antibody staining results contradict functional adhesion assay outcomes, consider these methodological interventions:

  • Epitope accessibility analysis:

    • Compare multiple anti-SELP antibody clones recognizing different epitopes

    • Some functional domains may be masked in certain contexts while remaining detectable by antibodies targeting other regions

  • Activation state assessment:

    • SELP requires proper conformation for functional activity

    • Compare staining with activation-specific antibodies versus pan-SELP antibodies

    • Include positive controls with known activators (e.g., thrombin, histamine)

  • Calcium dependency evaluation:

    • SELP functional activity is calcium-dependent

    • Perform parallel staining in calcium-containing versus EDTA-containing buffers

    • Functional assays must include physiological calcium concentrations

  • Technical validation approaches:

    ApproachImplementationInterpretation
    Blocking studiesPre-treat cells with unlabeled antibody before functional assayConfirms antibody access to functional domains
    Domain-specific stainingUse antibodies against lectin, EGF, and complement-binding domainsIdentifies which domains are accessible
    Temperature effectsCompare staining at 4°C vs. 37°CReveals temperature-dependent conformational changes
    Fixation effectsCompare live vs. fixed cell stainingDetermines if fixation alters epitope accessibility
  • Reconciliation strategies:

    • Quantify surface vs. total SELP expression (surface may not reflect functional pool)

    • Evaluate density-dependent effects (functional adhesion may require threshold density)

    • Consider post-translational modifications affecting function but not antibody binding

These approaches help resolve apparent contradictions between antibody detection and functional activity, providing deeper insights into SELP biology.

How can I optimize FITC-conjugated SELP antibody protocols for imaging flow cytometry to analyze subcellular localization?

Imaging flow cytometry combines the quantitative power of flow cytometry with the spatial resolution of microscopy. To optimize FITC-conjugated SELP antibody protocols for this application:

  • Signal optimization parameters:

    • Increase antibody concentration slightly (0.5-1.0 μg per test) to improve signal intensity

    • Add an anti-FITC antibody amplification step if needed

    • Use nuclear and membrane counterstains with spectrally distinct fluorophores

  • Sample preparation refinements:

    • Optimize fixation carefully (2-4% paraformaldehyde for 10-15 minutes)

    • If permeabilizing, use gentle detergents (0.1% saponin rather than Triton X-100)

    • Include cytoskeletal stabilization steps if analyzing cytoskeletal associations

  • Instrument settings optimization:

    • Adjust the core stream width to maximize cell centricity

    • Implement extended depth of field if available

    • Use brightfield imagery to confirm intact cell morphology

  • Controls for subcellular localization:

    • Include markers for relevant subcellular compartments (e.g., membrane, endosomes, granules)

    • Use colocalization analysis (similarity score, bright detail similarity)

    • Perform time-course studies to track SELP trafficking

  • Data analysis considerations:

    • Implement mask features to define subcellular regions

    • Calculate internalization scores to quantify surface versus internal SELP

    • Use ideas analysis software features for colocalization mapping

This approach enables precise quantification of SELP localization patterns across large cell populations, revealing heterogeneity impossible to detect with conventional microscopy or flow cytometry alone.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.